Australia markets closed

Cocrystal Pharma Inc (8CC.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
1.4300+0.0200 (+1.42%)
As of 08:06AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
2,014
Operating expenses
Research development
15,169
15,169
12,392
8,794
6,034
Selling general and administrative
5,990
5,990
5,745
5,427
5,566
Total operating expenses
21,159
21,159
18,137
14,221
11,600
Operating income or loss
-21,159
-21,159
-18,137
-14,221
-9,586
Interest expense
-
-
2
4
8
Total other income/expenses net
2,535
2,535
-20,698
40
-54
Income before tax
-17,984
-17,984
-38,837
-14,185
-9,648
Income tax expense
-
-
-
-
0
Income from continuing operations
-17,984
-17,984
-38,837
-14,185
-9,648
Net income
-17,984
-17,984
-38,837
-14,185
-9,648
Net income available to common shareholders
-17,984
-17,984
-38,837
-14,185
-9,648
Basic EPS
-1.97
-
-4.77
-0.16
-2.04
Diluted EPS
-1.97
-
-4.77
-0.16
-2.04
Basic average shares
9,132
-
8,143
7,364
4,601
Diluted average shares
9,132
-
8,143
7,364
4,601